文献速递肝胆胰外科围术期管理与 ERAS

术后血清胰淀粉酶持续升高可预测胰腺手术并发症

Early and Sustained Elevation in Serum Pancreatic Amylase Activity: A Novel Predictor of Morbidity After Pancreatic Surgery.
PubMed 文献 · Ann Surg · 2021-04-30

该研究分析2016至2019年连续接受胰腺切除术的患者,根据术后第0至3天血清胰淀粉酶(spAMY)相对于正常范围(10-52 U/l)的变化识别出三种模式。模式3(POD1+2持续升高)与总体并发症、严重并发症及术后胰瘘(POPF)风险显著增加相关,且术前糖尿病、新辅助治疗、胰腺质地、胰管直径和最终组织学是模式3的独立预测因素。

要点

  • 术后spAMY呈现三种模式,模式3(POD1+2持续升高)提示并发症风险最高。
  • 模式3患者严重并发症(Clavien-Dindo≥3)发生率为15%,显著高于其他模式。
  • POPF发生率从模式1的9%逐步升至模式3的48%。

核心结论

  • 术后spAMY持续升高(包括POD1+2)是早期总体和严重并发症的预测因素。

研究设计与样本

  • 分析2016至2019年连续接受胰腺切除术的患者,从术后第0至3天评估spAMY活性,基于spAMY标准范围(10-52 U/l)识别不同模式。

主要发现

  • 识别出三种spAMY模式:模式1(spAMY始终低于正常下限/在参考范围内/任何POD单次升高超过正常上限);模式2(POD0+1持续升高);模式3(包括POD1+2持续升高)。
  • 模式转变与发病率增加相关(POD7时从模式1的21%升至模式3的68%,log rank P < 0.001)。
  • 几乎所有严重并发症(至少Clavien-Dindo≥3)发生在模式3患者中(POD7时模式3为15%,模式1为3%,模式2为5%,P = 0.006),而考虑>3倍或>spAMY正常上限时无差异(P = 0.85)。
  • POPF发生率随模式递增(模式1为9%,模式3为48%,P < 0.001)。
  • 术前糖尿病(OR 0.19)、新辅助治疗(OR 0.22)、胰腺质地(OR 8.8)、胰管直径(OR 0.78)和最终组织学(OR 2.2)是模式3的独立预测因素。

关键数值与推荐

  • spAMY标准范围为10-52 U/l。
  • 模式3定义为包括POD1+2的spAMY活性持续升高。
  • 严重并发症定义为Clavien-Dindo≥3。

临床怎么用

  • 术后早期动态评估spAMY有助于识别高风险患者,可能影响后续临床病程管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize early postoperative serum pancreatic amylase (spAMY) trends after pancreatic resections. SUMMARY BACKGROUND DATA: A postoperative spAMY elevation is a common finding but uncertainties remain about its meaning and prognostic implications. METHODS: Analysis of patients who consecutively underwent pancreatectomy from 2016 to 2019. spAMY activity was assessed from postoperative day (POD) 0 to 3. Different patterns of spAMY have been identified based on the spAMY standard range (10-52 U/l). RESULTS: Three patterns were identified: (#1) spAMY values always < the lower limit of normal/within the reference range /a single increase in spAMY > upper limit of normal at any POD; (#2) Sustained increase in spAMY activity on POD 0 + 1; (#3) Sustained increase in spAMY activity including POD 1 + 2. Shifting through spAMY patterns was associated with increase morbidity (21% in #1 to 68% in #3 at POD 7; log rank < 0.001). Almost all severe complications (at least Clavien-Dindo ≥3) occurred in patients with pattern #3 (15% vs 3% vs 5% in #1 and #2 at POD 7, P = 0.006), without difference considering >3-times or >the spAMY normal limit ( P = 0.85). POPF (9% in #1 vs 48% in #3, P < 0.001) progressively increased across patterns. Pre-operative diabetes (OR 0.19), neoadjuvant therapy (OR 0.22), pancreatic texture (OR 8.8), duct size (OR 0.78), and final histology (OR 2.2) were independent predictors of pattern #3. CONCLUSIONS: A sustained increase in spAMY activity including POD 1 + 2 (#3) represents an early postoperative predictor of overall and severe early morbidity. An early and dynamic evaluation of spAMY could crucially impact the subsequent clinical course with relevant prognostic implications.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Bannone E, Marchegiani G, Balduzzi A, et al. Early and Sustained Elevation in Serum Pancreatic Amylase Activity: A Novel Predictor of Morbidity After Pancreatic Surgery. Ann Surg. 2021. PMID: 33938491. doi:10.1097/SLA.0000000000004921

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。